Imiquimod Cream: A New Multipurpose Topical Therapy for Dermatology

P and T

Volumn 28, Issue 2, 2003, Pages 122-127

  Najarian, David J ^a   English III, Joseph C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADAPALENE; CIMETIDINE; DACARBAZINE; FAMCICLOVIR; FLUOROURACIL; IMIQUIMOD; MEGLUMINE ANTIMONATE; PODOPHYLLIN; RETINOIC ACID; STEROID; SULINDAC; VALACICLOVIR;

ACTINIC KERATOSIS; ALOPECIA; ANTIVIRAL ACTIVITY; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; BOWENOID PAPULOSIS; CARCINOMA IN SITU; CONDYLOMA; DRUG INDICATION; DRUG USE; ERYTHEMA; FOOD AND DRUG ADMINISTRATION; GENITAL HERPES; HEMANGIOMA; HUMAN; KELOID; MELANOMA; MOLLUSCUM CONTAGIOSUM; POROKERATOSIS MIBELLI; REVIEW; SKIN DISEASE; SKIN LEISHMANIASIS; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; T CELL LYMPHOMA; TATTOO; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA PLANA JUVENILIS; VERRUCA VULGARIS; VULVA TUMOR;

EID: 0344270951     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Tyring S, Arany I, Stanley M, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998;178:551-555.
2. Saunder D. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000;43:S6-S11.
3. Todd R, Etherington I, Luesley D. The effects of 5% imiquimod cream on high-grade vulval intraepithelial neoplasia. Gynecol Oncol 2002;85:67-70.
4. Beutner K, Geisse J, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod cream 5%. J Am Acad Dermatol 1999;41:895.
5. Smith K, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001;27:561-564.
6. Schroeder T, Sengelmann R. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002;46:545-548.
7. Workowski K, Levine W. Sexually transmitted diseases treatment guidelines-2002. MMWR Morb Mortal Wkly Rep 2002;51(RR-6).
8. Edwarts L, Ferenczy A, Eron L, et al, and the HPV Study Group. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30.
9. French L, Nashelsky J, White D. What is the most effective treatment for external genital warts? J Fam Pract 2002;51:313.
10. Langley P, Tyring S, Smith M. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Manag Care 1999;5:69-77.
11. Hengge U, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000;143:1026-1031.
12. Schwab R, Elston D. Topical imiquimod for recalcitrant facial flat warts. Cutis 2000;65:160-162.
13. Oster-Schmidt C. Imiquimod: A new possibility for treatment-resistant verrucae planae. Arch Dermatol 2001;137:666-667.
14. Rinne D, Linhart C, Schofer H. Lip papillomatosis in immunodeficiency: Therapy with imiquimod. Br J Dermatol 2000;142:196-197.
15. Sparling J, Checketts S, Chapman M. Imiquimod for plantar and periungual warts. Cutis 2001;68:397-399.
16. Syed TA, Goswami J, Ahmadpour OA, Ahmad SA. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: A placebo-controlled, double-blind study. J Dermatol 1998;25:309-313.
17. Skinner R Jr, Ray S, Talanin N. Treatment of molluscum contagiosum with topical 5% imiquimod cream. Pediatr Dermatol 2000;17:420.
18. Brown C, O'Donoghue M, Moore J, Tharp M. Recalcitrant molluscum contagiosum in an HIV-1 afflicted male treated successfully with topical imiquimod. Cutis 2000;65:363-366.
19. Buckley R, Smith K. Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease. Arch Dermatol 1999;135:1167-1169.
20. Miller RI, Imbertson LM, Reiter MJ, Gerster JF. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod. Antiviral Res 1999;44:31-42.
21. Harrison CJ, Jenski L, Voychehovski T, Bernstein DI. Modification of immunological responses and clinical disease during R-837 treatment of genital HSV-2 infection. Antiviral Res 1988;10:209-224.
22. Bernstein DI, Harrison CJ. Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections. Antimicrob Agents Chemother 1989;33:1511-1515.
23. Harrison CJ, Miller RL, Bernstein DI. Post-therapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother 1994;38:2059-2064.
24. Gilbert J, Drehs M, Weinberg J. Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol 2001;137:1015-1017.
25. Christensen B, Hengge U. Recurrent urogenital herpes simplex: Successful treatment with imiquimod? Sex Transm Infect 1999;75:132-133.
26. Smith K, Germain M, Skelton H. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a COX inhibitor, sulindac: Potential applications for this combination of immunotherapy. Dermatol Surg 2001;27:143-146.
27. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases. Br J Dermatol 2001;144:1050-1053.
28. Mackenzie-Wood A, Kossard S, de Launey J, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001;44:462-470.
29. 19F-magnetic resonance spectroscopy. J Clin Oncol 2000;18:255-261.
30. Bekradda M, Cvitkovic E. New possibilities in chemotherapy for colorectal cancer. Ann Oncol 1999;10:105-111.
31. Pehoushek M, Smith K. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1 positive man. Arch Dermatol 2001;137:14-16.
32. Cook-Bolden F, Weinberg J. Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis. J Am Acad Dermatol 2002;46:146-147.
33. Petrow W, Gerdsen R, Uerlich M, et al. Successful topical immunotherapy of bowenoid papulosis with imiquimod. Br J Dermatol 2001;145:1022-1036.
34. Davis G, Wentworth J, Richard J. Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. J Reprod Med 2000;45:619-623.
35. Diaz-Arrastia C, Arany I, Robazetti S, et al. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res 2001;7:3031-3033.
36. Diakomanolis E, Haidopoulos D, Stefanidis K. Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream. N Engl J Med 2002;347:374.
37. Marks R, Bebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001;44:807-813.
38. Ahmed I, Berth-Jones J. Imiquimod: A novel treatment for lentigo maligna. Br J Dermatol 2000;143:843-845.
39. Steinmann A, Funk J, Schuler G, Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 2000;43:555-556.
40. Agarwal S, Berth-Jones J. Porokeratosis of Mibelli: Successful treatment with 5% imiquimod cream. Br J Dermatol 2002;146:338-339.
41. Buates S, Matlashewski G. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S28463: Efficacy and mode of action. J Infect Dis 1999;179:1485-1494.
42. Arevalo I, Ward B, Miller R, et al. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 2001;33:1847-1851.
43. Solis R, Diven D, Colome-Grimmer C, et al. Experimental nonsurgical tattoo removal in a guinea pig model with topical imiquimod and tretinoin. Dermatol Surg 2002;28:83-87.
44. Dahl M. Imiquimod: An immune response modifier. J Am Acad Dermatol 2000;43:S1-S5.
45. Kashani-Sabet M. Toward the biologic treatment of nonmelanoma skin cancer. J Am Acad Dermatol 1999;41:1018-1019.
46. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002;47(4):S209-S211.
47. Martinez, M, Sanchez-Carpintero I, North P, Mihm M Jr. Infantile hemangioma clinical resolution with 5% imiquimod cream. Arch Dermatol 2002;138:881-884.
48. Physicians' Desk Reference, 57th ed. Montvale, NJ: Thomson/Medical Economics; 2003:1882-1883.
49. Available at: www.drugstore.com/pharmacy/prices/drugprice. asp?ndc=0089061012. Retrieved January 17, 2003.